CLOVER HEALTH INVESTMENTS CORP CLA (CLOV) — insider trading
Health Care · NASDAQ
CLOVER HEALTH INVESTMENTS CORP CLA (CLOV) has 43 reported SEC Form 4 insider transactions in our data, including 29 open-market sales among the most recent 43 (latest 2026-10-07).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-07 | Reynoso Jamie L. | Officer (CEO, Medicare Advantage) | Open-market sale | 2,006 | $4.63 | $9.3K | Form 4 |
| 2026-10-05 | Reynoso Jamie L. | Officer (CEO, Medicare Advantage) | Open-market sale | 8,750 | $4.42 | $38.7K | Form 4 |
| 2026-10-01 | Toy Andrew | Director, Officer (Chief Executive Officer) | Open-market sale | 318,806 | $4.19 | $1.34M | Form 4 |
| 2026-09-30 | Miller Brian James | Director | Grant / award / vesting | 12,481 | — | $0 | Form 4 |
| 2026-09-30 | Torricelli Robert G | Director | Grant / award / vesting | 12,481 | — | $0 | Form 4 |
| 2026-09-17 | Reynoso Jamie L. | Officer (CEO, Medicare Advantage) | Open-market sale | 1,921 | $4.56 | $8.8K | Form 4 |
| 2026-09-16 | OLDAKOWSKI JOSEPH FRANK | Officer (VP OF FINANCE AND CONTROLLER) | Open-market sale | 3,170 | $4.64 | $14.7K | Form 4 |
| 2026-09-15 | Wai Conrad | Officer (CEO, Counterpart Health) | Open-market sale | 300,000 | $4.72 | $1.42M | Form 4 |
| 2026-09-15 | Reynoso Jamie L. | Officer (CEO, Medicare Advantage) | Open-market sale | 9,273 | $4.78 | $44.3K | Form 4 |
| 2026-09-15 | Soares Karen | Officer (Chief Legal Officer) | Open-market sale | 6,846 | $4.78 | $32.7K | Form 4 |
| 2026-09-14 | OLDAKOWSKI JOSEPH FRANK | Officer (VP OF FINANCE AND CONTROLLER) | Open-market sale | 20,000 | $5.16 | $103.2K | Form 4 |
| 2026-08-17 | THORNTON JOSEPH CLAY | Officer (Interim CFO) | Open-market sale | 17,775 | $4.39 | $78.0K | Form 4 |
| 2026-08-12 | THORNTON JOSEPH CLAY | Officer (Interim CFO) | Grant / award / vesting | 54,347 | — | $0 | Form 4 |
| 2026-08-12 | Soares Karen | Officer (Chief Legal Officer) | Grant / award / vesting | 108,695 | — | $0 | Form 4 |
| 2026-08-10 | Toy Andrew | Director, Officer (Chief Executive Officer) | Open-market sale | 87,798 | $4.65 | $408.3K | Form 4 |
| 2026-07-20 | Soares Karen | Officer (Chief Legal Officer) | Open-market sale | 51,700 | $4.51 | $233.2K | Form 4 |
| 2026-07-17 | Reynoso Jamie L. | Officer (CEO, Medicare Advantage) | Open-market sale | 4,839 | $4.53 | $21.9K | Form 4 |
| 2026-07-15 | THORNTON JOSEPH CLAY | Officer (Interim CFO) | Open-market sale | 4,630 | $4.67 | $21.6K | Form 4 |
| 2026-07-15 | Soares Karen | Officer (Chief Legal Officer) | Open-market sale | 10,519 | $4.67 | $49.1K | Form 4 |
| 2026-07-15 | Reynoso Jamie L. | Officer (CEO, Medicare Advantage) | Open-market sale | 13,119 | $4.67 | $61.3K | Form 4 |
| 2026-07-15 | Wai Conrad | Officer (CEO, Counterpart Health) | Open-market sale | 24,215 | $4.67 | $113.1K | Form 4 |
| 2026-07-15 | Toy Andrew | Director, Officer (Chief Executive Officer) | Open-market sale | 62,711 | $4.67 | $292.9K | Form 4 |
| 2026-07-08 | Reynoso Jamie L. | Officer (CEO, Medicare Advantage) | Open-market sale | 2,384 | $4.68 | $11.2K | Form 4 |
| 2026-07-06 | Reynoso Jamie L. | Officer (CEO, Medicare Advantage) | Open-market sale | 6,229 | $5.26 | $32.8K | Form 4 |
| 2026-07-01 | Toy Andrew | Director, Officer (Chief Executive Officer) | Open-market sale | 313,476 | $5.32 | $1.67M | Form 4 |
| 2026-06-17 | Reynoso Jamie L. | Officer (CEO, Medicare Advantage) | Open-market sale | 2,360 | $4.78 | $11.3K | Form 4 |
| 2026-06-16 | OLDAKOWSKI JOSEPH FRANK | Officer (VP OF FINANCE AND CONTROLLER) | Open-market sale | 12,102 | $4.86 | $58.8K | Form 4 |
| 2026-06-15 | Reynoso Jamie L. | Officer (CEO, Medicare Advantage) | Open-market sale | 6,350 | $4.61 | $29.3K | Form 4 |
| 2026-06-15 | Soares Karen | Officer (Chief Legal Officer) | Open-market sale | 4,681 | $4.61 | $21.6K | Form 4 |
| 2026-06-11 | Reynoso Jamie L. | Officer (CEO, Medicare Advantage) | Open-market sale | 7,289 | $4.91 | $35.8K | Form 4 |
| 2026-05-28 | Wai Conrad | Officer (CEO, Counterpart Health) | Open-market sale | 220,426 | $3.99 | $879.5K | Form 4 |
| 2026-05-18 | Edwards Carladenise Armbrister | Director | Open-market sale | 67,160 | $3.42 | $229.7K | Form 4 |
| 2026-05-16 | THORNTON JOSEPH CLAY | Officer (Interim CFO) | Shares withheld for taxes / exercise cost | 16,942 | $3.47 | $58.8K | Form 4 |
| 2026-05-13 | Priest Brady Patrick | Officer (CEO of Clover Care Services) | Open-market sale | 98,039 | $3.52 | $345.1K | Form 4 |
| 2026-05-08 | Toy Andrew | Director, Officer (Chief Executive Officer) | Shares withheld for taxes / exercise cost | 85,704 | $2.82 | $241.7K | Form 4 |
| 2026-04-18 | Priest Brady Patrick | Officer (CEO of Clover Care Services) | Shares withheld for taxes / exercise cost | 36,113 | $2.19 | $79.1K | Form 4 |
| 2026-04-15 | Wai Conrad | Officer (CEO, Counterpart Health) | Shares withheld for taxes / exercise cost | 23,463 | $2.04 | $47.9K | Form 4 |
| 2026-04-15 | Reynoso Jamie L. | Officer (CEO, Medicare Advantage) | Shares withheld for taxes / exercise cost | 12,712 | $2.04 | $25.9K | Form 4 |
| 2026-04-15 | THORNTON JOSEPH CLAY | Officer (Interim CFO) | Shares withheld for taxes / exercise cost | 4,158 | $2.04 | $8.5K | Form 4 |
| 2026-04-15 | Toy Andrew | Director, Officer (Chief Executive Officer) | Shares withheld for taxes / exercise cost | 60,765 | $2.04 | $124.0K | Form 4 |
| 2026-04-15 | Soares Karen | Officer (Chief Legal Officer) | Shares withheld for taxes / exercise cost | 10,161 | $2.04 | $20.7K | Form 4 |
| 2026-04-15 | Priest Brady Patrick | Officer (CEO of Clover Care Services) | Shares withheld for taxes / exercise cost | 15,471 | $2.04 | $31.6K | Form 4 |
| 2026-04-03 | Reynoso Jamie L. | Officer (CEO, Medicare Advantage) | Shares withheld for taxes / exercise cost | 6,197 | $1.72 | $10.7K | Form 4 |
Ask the chat about CLOV's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: CLOVER HEALTH INVESTMENTS CORP CLA (CLOV).
Last updated 2026-10-07 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.